{"id":359926,"date":"2025-08-30T11:20:45","date_gmt":"2025-08-30T11:20:45","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-surgery-partners\/"},"modified":"2025-08-30T11:20:45","modified_gmt":"2025-08-30T11:20:45","slug":"how-to-buy-surgery-partners","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/","title":{"rendered":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-359926","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Surgery Partners, Inc. (SGRY) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu sa\u011fl\u0131k sekt\u00f6r\u00fc hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, b\u00fcy\u00fcme potansiyeli ve 2025 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejilerini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Surgery Partners, Inc. (SGRY) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu sa\u011fl\u0131k sekt\u00f6r\u00fc hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, b\u00fcy\u00fcme potansiyeli ve 2025 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejilerini ke\u015ffedin."},"intro":"H\u0131zla b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fcne yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Surgery Partners, Inc. (SGRY), b\u00fcy\u00fcyen ayaktan cerrahi pazar\u0131na eri\u015fim i\u00e7in benzersiz bir f\u0131rsat sunuyor. Ya\u015flanan n\u00fcfuslar ve artan sa\u011fl\u0131k hizmetleri talebi ile bu \u015firket portf\u00f6y b\u00fcy\u00fcmeniz i\u00e7in biletiniz olabilir. SGRY hissesine yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi birlikte inceleyelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"H\u0131zla b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fcne yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Surgery Partners, Inc. (SGRY), b\u00fcy\u00fcyen ayaktan cerrahi pazar\u0131na eri\u015fim i\u00e7in benzersiz bir f\u0131rsat sunuyor. Ya\u015flanan n\u00fcfuslar ve artan sa\u011fl\u0131k hizmetleri talebi ile bu \u015firket portf\u00f6y b\u00fcy\u00fcmeniz i\u00e7in biletiniz olabilir. SGRY hissesine yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi birlikte inceleyelim."},"body_html":"<h2>\ud83d\udcc8 Surgery Partners Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla Surgery Partners, Inc. (SGRY), NASDAQ borsas\u0131nda <strong>22,82 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>11 Kas\u0131m 2025<\/strong> kesinlikle kritik bir tarih. Bu tarihte Surgery Partners \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 SGRY Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>5 A\u011fustos 2025 tarihli son kazan\u00e7 raporu etkileyici sonu\u00e7lar g\u00f6sterdi - \u015firket hem gelir hem de kazan\u00e7 beklentilerini a\u015ft\u0131. Gelir 816,96 milyon $ beklentisine kar\u015f\u0131l\u0131k 826,20 milyon $ olarak ger\u00e7ekle\u015firken, hisse ba\u015f\u0131na kazan\u00e7 (EPS) 0,16 $ olan konsens\u00fcs tahminini 0,17 $ ile ge\u00e7ti (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-5-surgery-partners-inc-stock\/\">MarketBeat Kazan\u00e7 Raporu<\/a>). Bu olumlu s\u00fcrpriz genellikle yukar\u0131 y\u00f6nl\u00fc ivme yarat\u0131r.<\/p> <p>Son d\u00f6neme bakacak olursak:<\/p> <ul> <li><strong>A\u011fustos 2025<\/strong>: Kazan\u00e7lar etraf\u0131nda hisse 22,49-22,69 $ aras\u0131nda i\u015flem g\u00f6rd\u00fc<\/li> <li><strong>\u00d6nceki \u00e7eyrekler<\/strong>: Genellikle kazan\u00e7 sonras\u0131 %3-8 fiyat dalgalanmalar\u0131<\/li> <li><strong>Desen<\/strong>: Beklentileri a\u015fan sonu\u00e7lar kal\u0131c\u0131 kazan\u00e7lara, beklentilerin alt\u0131nda kalanlar ge\u00e7ici d\u00fc\u015f\u00fc\u015flere yol a\u00e7ar<\/li> <\/ul> <p>\u015eirketin 2025 i\u00e7in 3,3-3,45 milyar $ gelir rehberli\u011fi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, Kas\u0131m raporu \u00f6zellikle etkili olabilir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2> <p>Surgery Partners son alt\u0131 ayda olduk\u00e7a dalgal\u0131 bir seyir izledi! Mart'tan A\u011fustos 2025'e kadar hisse, piyasa volatilitesine ra\u011fmen kayda de\u011fer bir diren\u00e7 g\u00f6sterdi.<\/p> <h3>Fiyat Hareketlerinin Detaylar\u0131:<\/h3> <ul> <li><strong>Mart 2025<\/strong>: 24-25 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li> <li><strong>Nisan-May\u0131s<\/strong>: 19-20 $ seviyelerine d\u00fc\u015f\u00fc\u015f (52 haftal\u0131k en d\u00fc\u015f\u00fck 18,87 $)<\/li> <li><strong>Haziran<\/strong>: 22-23 $ aral\u0131\u011f\u0131nda toparlanma<\/li> <li><strong>Temmuz-A\u011fustos<\/strong>: 22-23 $ seviyelerinde istikrar ve yukar\u0131 y\u00f6nl\u00fc momentum<\/li> <\/ul> <p>Hisse <strong>son bir ayda %6,01<\/strong> ve <strong>son bir haftada %4,74<\/strong> art\u0131\u015f g\u00f6stererek g\u00fc\u00e7l\u00fc bir toparlanma ivmesi sergiledi (<a href=\"https:\/\/stockinvest.us\/stock\/SGRY\">StockInvest Analizi<\/a>). Bu d\u00f6nemde 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesine ula\u015fmas\u0131na ra\u011fmen, SGRY etkileyici bir geri d\u00f6n\u00fc\u015f yetene\u011fi g\u00f6sterdi.<\/p> <p><strong>Volatilitenin sebebi nedir?<\/strong><br\/> Sa\u011fl\u0131k sekt\u00f6r\u00fc hisseleri genellikle d\u00fczenleyici haberler, kazan\u00e7 s\u00fcrprizleri ve genel piyasa duyarl\u0131l\u0131\u011f\u0131na tepki verir. Surgery Partners'\u0131n \u00f6zel zorluklar\u0131 aras\u0131nda k\u00e2rl\u0131l\u0131k endi\u015feleri ve bor\u00e7 seviyeleri vard\u0131, ancak son operasyonel iyile\u015ftirmeler yat\u0131r\u0131mc\u0131 g\u00fcvenini art\u0131rd\u0131.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, SGRY i\u00e7in gelecekte neler olabilir:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 32-35 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %40-50 y\u00fckseli\u015f)<br\/> Analistler b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser, ortalama fiyat hedefi 33,00 $ ve baz\u0131 hedefler 43,00 $ seviyesine kadar \u00e7\u0131k\u0131yor (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SGRY\/forecast\/\">MarketBeat Tahmini<\/a>). G\u00fc\u00e7l\u00fc ikinci \u00e7eyrek sonu\u00e7lar\u0131 ve s\u00fcrd\u00fcr\u00fclen rehberlik bu iyimserli\u011fi destekliyor.<\/li> <li><strong>2026 Projeksiyonu<\/strong>: 36-42 $ aral\u0131\u011f\u0131<br\/> B\u00fcy\u00fcme stratejisinin uygulanmas\u0131, portf\u00f6y optimizasyonu ve pazar geni\u015flemesi daha fazla de\u011fer art\u0131\u015f\u0131 sa\u011flamal\u0131d\u0131r.<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 45-55 $ aral\u0131\u011f\u0131<br\/> 2028 y\u0131l\u0131na kadar \u015firketin borcunu \u00f6nemli \u00f6l\u00e7\u00fcde azaltmas\u0131, tesis a\u011f\u0131n\u0131 geni\u015fletmesi ve b\u00fcy\u00fcyen ayaktan cerrahi pazar\u0131nda daha fazla pazar pay\u0131 yakalamas\u0131 bekleniyor.<\/li> <li><strong>2030 Vizyonu<\/strong>: 60-75+ $ potansiyel<br\/> Uzun vadeli demografik trendler (ya\u015flanan n\u00fcfus), sa\u011fl\u0131k maliyetleri bask\u0131lar\u0131 ve sekt\u00f6r konsolidasyonu potansiyeli SGRY'nin \u00e7ok daha y\u00fcksek de\u011ferlemelere ula\u015fmas\u0131n\u0131 sa\u011flayabilir.<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut fiyat, beklenen b\u00fcy\u00fcme \u00f6ncesi cazip bir giri\u015f noktas\u0131 sunuyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3> <ul> <li><strong>Y\u00fcksek bor\u00e7 y\u00fck\u00fc<\/strong>: 4,1x net bor\u00e7\/EBITDA oran\u0131 finansal k\u0131r\u0131lganl\u0131k yarat\u0131yor<\/li> <li><strong>K\u00e2rl\u0131l\u0131k zorluklar\u0131<\/strong>: Gelir art\u0131\u015f\u0131na ra\u011fmen son \u00e7eyreklerde zararlar<\/li> <li><strong>D\u00fczenleyici de\u011fi\u015fiklikler<\/strong>: Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri geri \u00f6deme oranlar\u0131n\u0131 etkileyebilir<\/li> <li><strong>Rekabet<\/strong>: Hastaneler ve di\u011fer cerrahi merkezlerden yo\u011fun rekabet<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3> <ul> <li><strong>Gelir b\u00fcy\u00fcmesi<\/strong>: 2025 ikinci \u00e7eyre\u011finde %8,4 y\u0131ll\u0131k b\u00fcy\u00fcme g\u00fc\u00e7l\u00fc operasyonel performans\u0131 g\u00f6steriyor<\/li> <li><strong>Marj geni\u015flemesi<\/strong>: D\u00fczeltilmi\u015f EBITDA marjlar\u0131 %16,0'dan %16,3'e y\u00fckseliyor<\/li> <li><strong>Stratejik reddetme<\/strong>: Bain Capital'in sat\u0131n alma teklifinin reddedilmesi, y\u00f6netimin daha y\u00fcksek de\u011fer g\u00f6rd\u00fc\u011f\u00fcn\u00fc g\u00f6steriyor<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Ya\u015flanan n\u00fcfus ve ayaktan bak\u0131m modeline ge\u00e7i\u015f i\u015f modeline fayda sa\u011fl\u0131yor<\/li> <li><strong>Analist g\u00fcveni<\/strong>: 16 analist taraf\u0131ndan takip ediliyor, \u00e7o\u011funluk Al \u00f6nerisi ve ortalama hedef 31 $<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <h3>Ciddi \u00d6neriler:<\/h3> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 temsil etmeyen bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li> <li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, birka\u00e7 hafta i\u00e7inde par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 11 Kas\u0131m kazan\u00e7 tarihini yak\u0131ndan takip edin<\/li> <\/ol> <p><strong>Esprili t\u00fcccar bilgeli\u011fi<\/strong>: \"Sa\u011fl\u0131k sekt\u00f6r\u00fc hisselerine yat\u0131r\u0131m yapmak doktora gitmek gibidir - bazen k\u0131sa vadede can\u0131n\u0131z yanar ama genellikle uzun vadeli sa\u011fl\u0131\u011f\u0131n\u0131z i\u00e7in iyidir. Sadece portf\u00f6y\u00fcn\u00fczde her g\u00fcn ameliyat yapmaya \u00e7al\u0131\u015fmay\u0131n!\"<\/p> <h2>\u2705 Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 22,82 $ (30 A\u011fustos 2025 itibar\u0131yla) kontrol edin<\/td><\/tr> <tr><td>4<\/td><td>Limit emri verin<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td><td>Kazan\u00e7 tarihleri ve sekt\u00f6r haberlerini d\u00fczenli olarak izleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, SGRY gibi hisselere yat\u0131r\u0131m yapmay\u0131 daha eri\u015filebilir k\u0131lan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - Stratejileri \u00f6nemli risk olmadan test etmek i\u00e7in ideal<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> - Minimum belge gereksinimi ile h\u0131zl\u0131 ba\u015flang\u0131\u00e7<\/li> <li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong> - Kazan\u00e7lar\u0131n\u0131za ihtiya\u00e7 duydu\u011funuzda eri\u015fim esnekli\u011fi<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, borsa piyasas\u0131nda yer almak ve yat\u0131r\u0131m bilgisini art\u0131rmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Surgery Partners: Sa\u011fl\u0131k Sekt\u00f6r\u00fcn\u00fcn B\u00fcy\u00fcme Motoru<\/h2> <p>Surgery Partners, Amerika Birle\u015fik Devletleri'nde 31 eyalette 200'den fazla lokasyona sahip en b\u00fcy\u00fck ayaktan cerrahi merkezleri a\u011flar\u0131ndan birini i\u015fletmektedir. \u015eirket, geleneksel hastane ortamlar\u0131na alternatif olarak maliyet etkin ayaktan cerrahi bak\u0131m sa\u011flamada uzmanla\u015fm\u0131\u015ft\u0131r.<\/p> <p>\u0130\u015f modeli, demografik trendler nedeniyle artan talep g\u00f6ren ortopedi, gastroenteroloji ve oftalmoloji gibi y\u00fcksek b\u00fcy\u00fcme alanlar\u0131na odaklanmaktad\u0131r. 2025 y\u0131l\u0131nda \u015firket, Kaliforniya'n\u0131n Bay Area b\u00f6lgesinde iki yeni cerrahi merkezi ile geni\u015flemesinden \u00f6zellikle heyecan duymaktad\u0131r.<\/p> <p><strong>2025 E\u011flenceli Ger\u00e7ek<\/strong>: Surgery Partners, Haziran 2025'te Bain Capital'in sat\u0131n alma teklifini g\u00fcvenle reddederek ba\u011f\u0131ms\u0131z kalmay\u0131 tercih etti ve y\u00f6netim, hissedarlar i\u00e7in daha fazla de\u011fer yaratabileceklerine inand\u0131\u011f\u0131 i\u00e7in bu karar\u0131 ald\u0131. Bu cesur hamle, b\u00fcy\u00fcme stratejilerine ve ba\u011f\u0131ms\u0131z potansiyellerine olan g\u00fc\u00e7l\u00fc g\u00fcveni g\u00f6sterdi!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Surgery Partners Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla Surgery Partners, Inc. (SGRY), NASDAQ borsas\u0131nda <strong>22,82 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>11 Kas\u0131m 2025<\/strong> kesinlikle kritik bir tarih. Bu tarihte Surgery Partners \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 SGRY Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>5 A\u011fustos 2025 tarihli son kazan\u00e7 raporu etkileyici sonu\u00e7lar g\u00f6sterdi &#8211; \u015firket hem gelir hem de kazan\u00e7 beklentilerini a\u015ft\u0131. Gelir 816,96 milyon $ beklentisine kar\u015f\u0131l\u0131k 826,20 milyon $ olarak ger\u00e7ekle\u015firken, hisse ba\u015f\u0131na kazan\u00e7 (EPS) 0,16 $ olan konsens\u00fcs tahminini 0,17 $ ile ge\u00e7ti (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-5-surgery-partners-inc-stock\/\">MarketBeat Kazan\u00e7 Raporu<\/a>). Bu olumlu s\u00fcrpriz genellikle yukar\u0131 y\u00f6nl\u00fc ivme yarat\u0131r.<\/p>\n<p>Son d\u00f6neme bakacak olursak:<\/p>\n<ul>\n<li><strong>A\u011fustos 2025<\/strong>: Kazan\u00e7lar etraf\u0131nda hisse 22,49-22,69 $ aras\u0131nda i\u015flem g\u00f6rd\u00fc<\/li>\n<li><strong>\u00d6nceki \u00e7eyrekler<\/strong>: Genellikle kazan\u00e7 sonras\u0131 %3-8 fiyat dalgalanmalar\u0131<\/li>\n<li><strong>Desen<\/strong>: Beklentileri a\u015fan sonu\u00e7lar kal\u0131c\u0131 kazan\u00e7lara, beklentilerin alt\u0131nda kalanlar ge\u00e7ici d\u00fc\u015f\u00fc\u015flere yol a\u00e7ar<\/li>\n<\/ul>\n<p>\u015eirketin 2025 i\u00e7in 3,3-3,45 milyar $ gelir rehberli\u011fi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, Kas\u0131m raporu \u00f6zellikle etkili olabilir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2>\n<p>Surgery Partners son alt\u0131 ayda olduk\u00e7a dalgal\u0131 bir seyir izledi! Mart&#8217;tan A\u011fustos 2025&#8217;e kadar hisse, piyasa volatilitesine ra\u011fmen kayda de\u011fer bir diren\u00e7 g\u00f6sterdi.<\/p>\n<h3>Fiyat Hareketlerinin Detaylar\u0131:<\/h3>\n<ul>\n<li><strong>Mart 2025<\/strong>: 24-25 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li>\n<li><strong>Nisan-May\u0131s<\/strong>: 19-20 $ seviyelerine d\u00fc\u015f\u00fc\u015f (52 haftal\u0131k en d\u00fc\u015f\u00fck 18,87 $)<\/li>\n<li><strong>Haziran<\/strong>: 22-23 $ aral\u0131\u011f\u0131nda toparlanma<\/li>\n<li><strong>Temmuz-A\u011fustos<\/strong>: 22-23 $ seviyelerinde istikrar ve yukar\u0131 y\u00f6nl\u00fc momentum<\/li>\n<\/ul>\n<p>Hisse <strong>son bir ayda %6,01<\/strong> ve <strong>son bir haftada %4,74<\/strong> art\u0131\u015f g\u00f6stererek g\u00fc\u00e7l\u00fc bir toparlanma ivmesi sergiledi (<a href=\"https:\/\/stockinvest.us\/stock\/SGRY\">StockInvest Analizi<\/a>). Bu d\u00f6nemde 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesine ula\u015fmas\u0131na ra\u011fmen, SGRY etkileyici bir geri d\u00f6n\u00fc\u015f yetene\u011fi g\u00f6sterdi.<\/p>\n<p><strong>Volatilitenin sebebi nedir?<\/strong><br \/> Sa\u011fl\u0131k sekt\u00f6r\u00fc hisseleri genellikle d\u00fczenleyici haberler, kazan\u00e7 s\u00fcrprizleri ve genel piyasa duyarl\u0131l\u0131\u011f\u0131na tepki verir. Surgery Partners&#8217;\u0131n \u00f6zel zorluklar\u0131 aras\u0131nda k\u00e2rl\u0131l\u0131k endi\u015feleri ve bor\u00e7 seviyeleri vard\u0131, ancak son operasyonel iyile\u015ftirmeler yat\u0131r\u0131mc\u0131 g\u00fcvenini art\u0131rd\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, SGRY i\u00e7in gelecekte neler olabilir:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 32-35 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %40-50 y\u00fckseli\u015f)<br \/> Analistler b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser, ortalama fiyat hedefi 33,00 $ ve baz\u0131 hedefler 43,00 $ seviyesine kadar \u00e7\u0131k\u0131yor (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SGRY\/forecast\/\">MarketBeat Tahmini<\/a>). G\u00fc\u00e7l\u00fc ikinci \u00e7eyrek sonu\u00e7lar\u0131 ve s\u00fcrd\u00fcr\u00fclen rehberlik bu iyimserli\u011fi destekliyor.<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 36-42 $ aral\u0131\u011f\u0131<br \/> B\u00fcy\u00fcme stratejisinin uygulanmas\u0131, portf\u00f6y optimizasyonu ve pazar geni\u015flemesi daha fazla de\u011fer art\u0131\u015f\u0131 sa\u011flamal\u0131d\u0131r.<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 45-55 $ aral\u0131\u011f\u0131<br \/> 2028 y\u0131l\u0131na kadar \u015firketin borcunu \u00f6nemli \u00f6l\u00e7\u00fcde azaltmas\u0131, tesis a\u011f\u0131n\u0131 geni\u015fletmesi ve b\u00fcy\u00fcyen ayaktan cerrahi pazar\u0131nda daha fazla pazar pay\u0131 yakalamas\u0131 bekleniyor.<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 60-75+ $ potansiyel<br \/> Uzun vadeli demografik trendler (ya\u015flanan n\u00fcfus), sa\u011fl\u0131k maliyetleri bask\u0131lar\u0131 ve sekt\u00f6r konsolidasyonu potansiyeli SGRY&#8217;nin \u00e7ok daha y\u00fcksek de\u011ferlemelere ula\u015fmas\u0131n\u0131 sa\u011flayabilir.<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut fiyat, beklenen b\u00fcy\u00fcme \u00f6ncesi cazip bir giri\u015f noktas\u0131 sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3>\n<ul>\n<li><strong>Y\u00fcksek bor\u00e7 y\u00fck\u00fc<\/strong>: 4,1x net bor\u00e7\/EBITDA oran\u0131 finansal k\u0131r\u0131lganl\u0131k yarat\u0131yor<\/li>\n<li><strong>K\u00e2rl\u0131l\u0131k zorluklar\u0131<\/strong>: Gelir art\u0131\u015f\u0131na ra\u011fmen son \u00e7eyreklerde zararlar<\/li>\n<li><strong>D\u00fczenleyici de\u011fi\u015fiklikler<\/strong>: Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri geri \u00f6deme oranlar\u0131n\u0131 etkileyebilir<\/li>\n<li><strong>Rekabet<\/strong>: Hastaneler ve di\u011fer cerrahi merkezlerden yo\u011fun rekabet<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3>\n<ul>\n<li><strong>Gelir b\u00fcy\u00fcmesi<\/strong>: 2025 ikinci \u00e7eyre\u011finde %8,4 y\u0131ll\u0131k b\u00fcy\u00fcme g\u00fc\u00e7l\u00fc operasyonel performans\u0131 g\u00f6steriyor<\/li>\n<li><strong>Marj geni\u015flemesi<\/strong>: D\u00fczeltilmi\u015f EBITDA marjlar\u0131 %16,0&#8217;dan %16,3&#8217;e y\u00fckseliyor<\/li>\n<li><strong>Stratejik reddetme<\/strong>: Bain Capital&#8217;in sat\u0131n alma teklifinin reddedilmesi, y\u00f6netimin daha y\u00fcksek de\u011fer g\u00f6rd\u00fc\u011f\u00fcn\u00fc g\u00f6steriyor<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Ya\u015flanan n\u00fcfus ve ayaktan bak\u0131m modeline ge\u00e7i\u015f i\u015f modeline fayda sa\u011fl\u0131yor<\/li>\n<li><strong>Analist g\u00fcveni<\/strong>: 16 analist taraf\u0131ndan takip ediliyor, \u00e7o\u011funluk Al \u00f6nerisi ve ortalama hedef 31 $<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<h3>Ciddi \u00d6neriler:<\/h3>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 temsil etmeyen bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li>\n<li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, birka\u00e7 hafta i\u00e7inde par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 11 Kas\u0131m kazan\u00e7 tarihini yak\u0131ndan takip edin<\/li>\n<\/ol>\n<p><strong>Esprili t\u00fcccar bilgeli\u011fi<\/strong>: &#8220;Sa\u011fl\u0131k sekt\u00f6r\u00fc hisselerine yat\u0131r\u0131m yapmak doktora gitmek gibidir &#8211; bazen k\u0131sa vadede can\u0131n\u0131z yanar ama genellikle uzun vadeli sa\u011fl\u0131\u011f\u0131n\u0131z i\u00e7in iyidir. Sadece portf\u00f6y\u00fcn\u00fczde her g\u00fcn ameliyat yapmaya \u00e7al\u0131\u015fmay\u0131n!&#8221;<\/p>\n<h2>\u2705 Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 22,82 $ (30 A\u011fustos 2025 itibar\u0131yla) kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit emri verin<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td>\n<td>Kazan\u00e7 tarihleri ve sekt\u00f6r haberlerini d\u00fczenli olarak izleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, SGRY gibi hisselere yat\u0131r\u0131m yapmay\u0131 daha eri\u015filebilir k\u0131lan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; Stratejileri \u00f6nemli risk olmadan test etmek i\u00e7in ideal<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> &#8211; Minimum belge gereksinimi ile h\u0131zl\u0131 ba\u015flang\u0131\u00e7<\/li>\n<li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Kazan\u00e7lar\u0131n\u0131za ihtiya\u00e7 duydu\u011funuzda eri\u015fim esnekli\u011fi<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, borsa piyasas\u0131nda yer almak ve yat\u0131r\u0131m bilgisini art\u0131rmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Surgery Partners: Sa\u011fl\u0131k Sekt\u00f6r\u00fcn\u00fcn B\u00fcy\u00fcme Motoru<\/h2>\n<p>Surgery Partners, Amerika Birle\u015fik Devletleri&#8217;nde 31 eyalette 200&#8217;den fazla lokasyona sahip en b\u00fcy\u00fck ayaktan cerrahi merkezleri a\u011flar\u0131ndan birini i\u015fletmektedir. \u015eirket, geleneksel hastane ortamlar\u0131na alternatif olarak maliyet etkin ayaktan cerrahi bak\u0131m sa\u011flamada uzmanla\u015fm\u0131\u015ft\u0131r.<\/p>\n<p>\u0130\u015f modeli, demografik trendler nedeniyle artan talep g\u00f6ren ortopedi, gastroenteroloji ve oftalmoloji gibi y\u00fcksek b\u00fcy\u00fcme alanlar\u0131na odaklanmaktad\u0131r. 2025 y\u0131l\u0131nda \u015firket, Kaliforniya&#8217;n\u0131n Bay Area b\u00f6lgesinde iki yeni cerrahi merkezi ile geni\u015flemesinden \u00f6zellikle heyecan duymaktad\u0131r.<\/p>\n<p><strong>2025 E\u011flenceli Ger\u00e7ek<\/strong>: Surgery Partners, Haziran 2025&#8217;te Bain Capital&#8217;in sat\u0131n alma teklifini g\u00fcvenle reddederek ba\u011f\u0131ms\u0131z kalmay\u0131 tercih etti ve y\u00f6netim, hissedarlar i\u00e7in daha fazla de\u011fer yaratabileceklerine inand\u0131\u011f\u0131 i\u00e7in bu karar\u0131 ald\u0131. Bu cesur hamle, b\u00fcy\u00fcme stratejilerine ve ba\u011f\u0131ms\u0131z potansiyellerine olan g\u00fc\u00e7l\u00fc g\u00fcveni g\u00f6sterdi!<\/p>\n"},"faq":[{"question":"Surgery Partners, Inc. (SGRY) hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emri verin ve yat\u0131r\u0131m\u0131n\u0131z\u0131 d\u00fczenli olarak takip edin."},{"question":"SGRY hissesinin g\u00fcncel fiyat\u0131 nedir?","answer":"30 A\u011fustos 2025 itibar\u0131yla SGRY hissesi NASDAQ'da 22,82 $ seviyesinden i\u015flem g\u00f6rmektedir."},{"question":"SGRY hissesi i\u00e7in 2025 sonras\u0131 fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda 32-35 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 60-75 $ ve \u00fczeri potansiyel fiyatlar beklenmektedir."},{"question":"SGRY hissesine yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Y\u00fcksek bor\u00e7 y\u00fck\u00fc, k\u00e2rl\u0131l\u0131k zorluklar\u0131, d\u00fczenleyici de\u011fi\u015fiklikler ve yo\u011fun rekabet temel riskler aras\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayanlar i\u00e7in SGRY hissesi yat\u0131r\u0131m\u0131 \u00f6nerileri nelerdir?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n ve \u00f6nemli kazan\u00e7 tarihlerini takip ederek fiyat uyar\u0131lar\u0131 kurun."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Surgery Partners, Inc. (SGRY) hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emri verin ve yat\u0131r\u0131m\u0131n\u0131z\u0131 d\u00fczenli olarak takip edin."},{"question":"SGRY hissesinin g\u00fcncel fiyat\u0131 nedir?","answer":"30 A\u011fustos 2025 itibar\u0131yla SGRY hissesi NASDAQ'da 22,82 $ seviyesinden i\u015flem g\u00f6rmektedir."},{"question":"SGRY hissesi i\u00e7in 2025 sonras\u0131 fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda 32-35 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 60-75 $ ve \u00fczeri potansiyel fiyatlar beklenmektedir."},{"question":"SGRY hissesine yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Y\u00fcksek bor\u00e7 y\u00fck\u00fc, k\u00e2rl\u0131l\u0131k zorluklar\u0131, d\u00fczenleyici de\u011fi\u015fiklikler ve yo\u011fun rekabet temel riskler aras\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayanlar i\u00e7in SGRY hissesi yat\u0131r\u0131m\u0131 \u00f6nerileri nelerdir?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n ve \u00f6nemli kazan\u00e7 tarihlerini takip ederek fiyat uyar\u0131lar\u0131 kurun."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T11:20:45+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T11:20:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/\",\"name\":\"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-30T11:20:45+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/","og_locale":"tr_TR","og_type":"article","og_title":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T11:20:45+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T11:20:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/","name":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-30T11:20:45+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-surgery-partners\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Surgery Partners, Inc. (SGRY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Surgery Partners, Inc. (SGRY) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":359925,"slug":"how-to-buy-surgery-partners","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Surgery Partners, Inc. (SGRY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Surgery Partners, Inc. (SGRY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-surgery-partners\/"},"pt_AA":{"locale":"pt_AA","id":359921,"slug":"how-to-buy-surgery-partners","post_title":"Como comprar a\u00e7\u00f5es da Surgery Partners, Inc. (SGRY) - Investimento em a\u00e7\u00f5es da Surgery Partners, Inc. (SGRY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-surgery-partners\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/359926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=359926"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/359926\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=359926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=359926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=359926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}